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A B S T R A C T
The sunlight was one of the first agents recognized to be carcinogenic for humans. There is convincing evidence from
epidemiologic studies that exposure to solar radiation is the major cause of cutaneous melanoma in light-pigmented pop-
ulations and plays a role in the increasing incidence of this malignancy. The molecular mechanisms by which UV radia-
tion exerts its varied effects are not completely understood, however, it is considered that UVA and UVB are equally criti-
cal players in melanoma formation. Whereas UVA can indirectly damage DNA through the formation of reactive oxygen
radicals, UVB can directly damage DNA causing the apoptosis of keratinocytes by forming the sunburn cells. Besides ac-
tion through mutations in critical regulatory genes, UV radiation may promote cancer through indirect mechanisms,
e.g. immunosuppression and dysregulation of growth factors. The carcinogenic process probably involves multiple se-
quential steps, some, but not all of which involve alterations in DNA structure.
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Introduction
Exposure to sunlight is a major factor in induction of
skin cancers including malignant melanoma, especially
in Caucasian population. Melanoma is a malignant tu-
mour arising from neural crest-derived melanocytes, pig-
mented cells presented normally in the epidermis and
sometimes in the dermis. During the past century, chan-
ges in clothing styles, recreational activities, longevity,
and other aspects of lifestyle have resulted in increased
exposure to sunlight1. Particularly, intermittent, recre-
ational exposure to UV component of sunlight associated
with sunburns plays an important role in melanoma
formation2. Excessive exposure of fair-skinned individu-
als to UV radiation, mainly natural sunlight presents an
environmental risk factor. Another major risk factor for
development of melanoma is genetic background of a pa-
tient. The genetic markers include three major genes:
CDKN2A gene on chromosome 9, CDK4 gene on chromo-
some 12 and gene on chromosome 13. However, in con-
trast to non-melanoma skin cancers, in which there are
distinctive UVB-induced mutations in the p53 gene, the
exact mechanisms and wavelengths by which sunlight
induces, promotes or contributes to the development of
melanoma have not been yet identified2. UVB (280–320
nm) is absorbed in nucleic acids and has been considered
the aetiological wavelength for melanoma4. Neverthe-
less, recent epidemiological studies have suggested that
UVA exposure increases the risk of melanoma even
though this is still debated5. The hypothesis that UVA is
important in the aetiology of melanoma is also supported
by epidemiological studies, in which exposure to UVA-
emitting sun beds was related to an increased melanoma
risk6. Several retrospective studies have assessed the risk
of melanoma in relation to sunscreen use7. One mecha-
nism by which sunscreens may lead to an increased mel-
anoma risk is that their use may allow prolonged inten-
sive sun exposures, which may increase the melanoma
risk.
UV Radiation and Malignant Melanoma
UVA and UVB are equally critical players in mela-
noma formation. However, data are conflicting on the
specific roles of UVA and UVB, which differ in their mo-
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lecular and biological ways of action. The predominant
component of sunlight is UVA which penetrates deeper
into skin than UVB due to longer wavelengths (Table 1).
Whereas UVA can indirectly damage DNA through the
formation of reactive oxygen radicals, UVB can directly
damage DNA causing the apoptosis of keratinocytes by
forming the sunburn cells8. Besides action through mu-
tations in critical regulatory genes, UV radiation may
promote cancer through indirect mechanisms, e.g. im-
munosuppression and dysregulation of growth factors9.
Overexpression in the skin of three growth factors for
melanocytes; basic fibroblast growth factor (bFGF), stem
cell factor (SCF) and endothelin (ET)-3, together with
UVB radiation, led to melanoma in vivo9. In contrast to
melanoma cells which produce different cytokines and
growth factors with paracrine and autocrine effects10,
melanocytes are dependent on the growth factor expres-
sion by neighbour cells, e.g. keratinocytes and fibro-
blasts11. An imbalance between stimulatory and inhibi-
tory factors provoked by exogenous stimuli, e.g. UV,
could activate the melanocytes and drive them towards
transformation by uncontrolled proliferation and migra-
tion9. UV radiation is, at the same time, a powerful stim-
ulus to melanin production and a destructive agent on
the melanocytes1. UV radiation can also serve as a tu-
mour promoter after an initiating dose of a chemical car-
cinogen. Thus UV radiation may play a variety of roles
during cutaneous carcinogenesis.
Immunology
Incomplete or complete regression of melanoma, oc-
currence of vitiligo-like depigmentation and halo nevi, as
well as higher rate of melanoma in immunosuppressed
patients point to the fact that melanoma is an immuno-
genic tumour12. The molecular characterization of mela-
noma antigens recognized by autologous T-cells or anti-
bodies was a scientific breakthrough13. The major me-
lanoma antigens include CDKN2A mutated antigen,
Mage-1,-3 and NY-ESO-1 that belong to the shared tu-
mour specific antigens and differentiation antigens like
tyrosinase, gp100, MelanA/MART-1. Their expression
can be followed in situ at the protein level using mono-
clonal antibodies. These proteins are processed inside
the cell and presented on the melanoma cell surface as
MHC/peptide complexes. CD8+ cytotoxic T-cells recog-
nize these antigens, and after appropriate activation, kill
such tumour cells in MHC-dependent manner through
release of cytotoxic granules (e.g. perforin and granzyme
B) or activation of FAS/TNF pathways2. CD8+ T-cells are
believed to be the major effector cells for an anti-mela-
noma-specific immune response, but CD4+ T-cells, as
well as antibodies, also play a critical role. Since mela-
noma is an immunogenic tumour, a variety of immune
escape mechanisms may be found in the advanced tu-
mours, e.g. loss of tumour-specific antigens, loss of MHC
class I molecules as well as secretion of immuno-inhibi-
tory cytokines such as IL-10 and TGF-beta14.
Genetics
p53 is a widely studied tumour suppressor gene that
has the ability to trigger cell-cycle arrest and apoptosis in
response to diverse stress stimuli. Under cellular stress,
such as hypoxia, DNA damage, ionizing radiation, expo-
sure to anticancer drugs and oncogene activation, the
p53 protein is rapidly accumulated in cells15–18. Depen-
ding on the extent of DNA damage, p53 can either bring
about cell cycle arrest in an effort to repair the damage,
or induce apoptosis when the damage is too severe19,20.
Apoptosis presents self-protective mechanism to elimi-
nate unnecessary or severely damaged cells. More than
half of all human tumours contain p53 mutations, and
most of the mutations are located in the DNA-binding
domain21. The p53 tumour suppressor gene is inactivated
by point mutations in approximately 50% of all human
tumours. Such a high mutation frequency indicates a
strong selection for loss of normal p53 function during
tumorigenesis22.
The most promising molecule in stabilising the p53
protein is CP-31398. After CP-31398 treatment, an in-
crease in the stability of p53 protein results in its active
conformation which correlates to apoptotic response.
However, CP-31398 was not able to revert all mutant p53
proteins to wild-type conformation and to induce apop-
tosis in all mutant p53 cell lines. The ability of CP-31398
to induce apoptosis through the intrinsic mitochondrial
pathway may well depend on the mutational status of
p53. Mutant p53 reactivation by small molecules has an
evident potential for the discovery of efficient and spe-
cific anti-cancer drugs23.
Molecular Mechanisms
The classic model of carcinogenesis includes four sta-
ges: initiation/induction, promotion, pre-malignant pro-
gression and malignant conversion (Table 2). Initiation
is the result of genetic damage caused by exogenous
agent (e.g. UV radiation) that alters cellular proliferative
controls and/or the differentiation pathway. Promotion
M. [itum et al.: UV Radiation in the Development of Malignant melanoma, Coll. Antropol. 31 (2007) Suppl. 1: 13–16
14
TABLE 1
WAVELENHGHTS OF THE NON-IONIZING RADIATION
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involves the expansion of the initiated cell population or
clone and is thought to be due to epigenetic effects. Pro-
gression and conversion are marked by cells with a high
level of genetic instability, chromosomal abnormalities,
surface substance expression and oncogene activity24.
The effects of non-ionizing radiations on human cells
rely on complex cellular interactions. Once radiation is
absorbed the molecule is raised to an excited state. In an
effort to dissipate the absorbed energy and return to the
resting state the energy can be converted to chemical
change which in turn results in biologic alterations.
UVB causes mutations and immunosuppressive ef-
fects essential to photo-carcinogenesis. UVB-induced
DNA damage leads to modifications in oncogene and tu-
mour suppressor gene expression, the most important
event in tumour initiation. UVB primarily affects the
epidermis causing disruption in DNA and the formation
of pyrimidine dimmers. In addition, UVB effects the pro-
duction of reactive oxygen species (e.g. hydrogen perox-
ide, superoxide anions and singlet oxygens). These in-
duce single strand breaks in DNA24. UVB and UVA
radiation both exert immunomodulatory effects. In addi-
tion, UV radiation may have other effects on the local en-
vironment in which the tumours develop, such as in-
creased vascularity and production of growth factors
that can contribute to tumour growth and progression.
The molecular mechanisms by which UV radiation ex-
erts its varied effects are not completely understood. The
carcinogenic process probably involves multiple sequen-
tial steps, some, but not all of which involve alterations
in DNA structure, e.g. mutations.
Prevention
The overall annual incidence and mortality rate of
melanoma is constantly rising in recent decades in all
parts of the world, with the highest rates in Australia.
Therefore the role of primary and secondary prevention
becomes crucial in reducing the lifetime risk of malig-
nant melanoma as well as other non-melanoma skin can-
cers. While secondary prevention with early detection is
the most effective strategy for those who sustained un-
protected sun exposure in youth, primary prevention by
effective sun protection throughout life for those at risk
to develop skin cancer may reduce the incidence of skin
cancer. However, according to the published clinical data,
there is no direct relationship between dose of UV radia-
tion and melanoma induction.
The protective role of sunscreens has been controver-
sial according to some epidemiological studies2. The in-
terpretation of these studies must be done with great
caution, because persons with a history of sunburn are
more likely to use sunscreens, so the higher risk may be
misinterpreted. One of the studies has indicated that
UVA sunscreen protection may be crucial in preventing
the efferent immune response suppression important in
tumour formation. It is reasonable to suppose that the
improvement in performance of modern sunscreens will
lead to a worthwhile benefit as a preventive agent against
melanoma, although these benefits may not be seen for
several decades25.
While speaking of prevention on in vitro basis, two
lipid soluble antioxidans,  -tocopherol and  -carotene,
have been shown to prevent UV-mediated oxidative
stress in keratinocytes and fibroblasts26,27.  -tocopherol
reduces cell proliferation, probably by affecting protein
kinase C dephosphorylation, which in turn reduces DNA-
binding capacity of the AP-1 transcription factor28,29.
 -tocopherol protection presents probably a combined ef-
fect of a decreased proliferation rate, providing time for
extended repair, and reduced level of oxidative stress re-
sulting in diminished apoptosis signalling. These effects
suggest a potent and broad UV protective capacity of
 -tocopherol affecting several cellular functions4. On the
other hand,  -carotene is protecting primary cultures of
melanocytes from UVA or UVB-induced oxidative stress,
which is less protective compared to the action of  -toco-
pherol. The balance between proliferation and apoptosis
might, in a longer perspective, have implications for the
risk of transformation and subsequent development of
melanoma. This is the basis for understanding the pro-
tective effect of  -tocopherol against UV-induced mela-
nocyte damage4.
In conclusion, the incidence of melanoma has in-
creased dramatically in the past 40 years. The reason for
this increase is uncertain but may involve increased rec-
reational sun exposure, especially early in life30. Routine
use of sunscreens, use of protective clothing, and avoid-
ing intense midday ultraviolet exposure should be recom-
mended. The patient should be educated in the clinical
features of melanoma and advised to report any growth
or other change in a pigmented lesion. Hopefully this
would rise awareness in general population and change
the outcome of the disease in the future.
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MEHANIZMI UV ZRA^ENJA U NASTANKU MALIGNOG MELANOMA
S A @ E T A K
Sun~eva svjetlost jedan je od prvih agenasa prepoznatih kao humani karcinogeni ~imbenik. Epidemiolo{ke studije
ukazale su na ~injenicu da je sun~eva svjetlost jedan od glavnih ~imbenika u nastanku malignog melanoma u bijelaca,
sa zna~ajnom ulogom u porastu incidencije tog malignog tumora. Molekularni mehanizmi kojima UZ zra~enje djeluje
na stanicu nisu jo{ u potpunosti razja{njeni, no smatra se da UVA i UVB zra~enje imaju jednako zna~ajnu ulogu u
nastanku melanoma. UVA zra~enje neizravno o{te}uje DNA prozivodnjom kisikovih slobodnih radikala, dok UVB iz-
ravno o{te}uje DNA uzrokuju}i apoptozu keratinocita nastankom stanica opeklina. Osim djelovanja na klju~ne regu-
lacijske gene, UV zra~enje mo`e utjecati na nastanak zlo}udnih tumora i drugim neizravnim mehanizmima kao npr.
imunosupresijom i poreme}enom regulacijom razli~itih faktora rasta. Karcinogeneza vjerojatno uklju~uje slo`eni kas-
kadni proces u kojem bitnu, ali ne i jedinu ulogu, ima promjena u strukturi DNA.
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